 | • レポートコード：GIR201105744 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ナイセリア淋病感染症治療の世界市場を調査対象にし、ナイセリア淋病感染症治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（クリブロスタチン-6、ダルババンシン、デビオ-1453、ゲポチダシンメシレート、その他）、用途別分析（クリニック、病院、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Allergan Plc、Paratek Pharmaceuticals, Inc.、Debiopharm International SA、BioDiem Ltd、Merck & Co., Inc.、Biolytics Pharma、Redx Pharma Plc、GlaxoSmithKline Plc、F. Hoffmann-La Roche Ltd.、Recce Pty Ltd、Sarepta Therapeutics, Inc.、Sumitomo Dainippon Pharma Co., Ltd. ・メーカー別販売量、売上、市場シェア ・ナイセリア淋病感染症治療の地域別市場分析 ・ナイセリア淋病感染症治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ナイセリア淋病感染症治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ナイセリア淋病感染症治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ナイセリア淋病感染症治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ナイセリア淋病感染症治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ナイセリア淋病感染症治療の種類別市場規模2015-2020：クリブロスタチン-6、ダルババンシン、デビオ-1453、ゲポチダシンメシレート、その他 ・ナイセリア淋病感染症治療の用途別市場規模2015-2020：クリニック、病院、その他 ・ナイセリア淋病感染症治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Neisseria Gonorrhoeae Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neisseria Gonorrhoeae Infections Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neisseria Gonorrhoeae Infections Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neisseria Gonorrhoeae Infections Treatment market has been segmented into
Cribrostatin-6
Dalbavancin
Debio-1453
Gepotidacin Mesylate
Others
By Application, Neisseria Gonorrhoeae Infections Treatment has been segmented into:
Clinic
Hospital
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neisseria Gonorrhoeae Infections Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Neisseria Gonorrhoeae Infections Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neisseria Gonorrhoeae Infections Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Neisseria Gonorrhoeae Infections Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neisseria Gonorrhoeae Infections Treatment Market Share Analysis
Neisseria Gonorrhoeae Infections Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neisseria Gonorrhoeae Infections Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neisseria Gonorrhoeae Infections Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Neisseria Gonorrhoeae Infections Treatment are:
Allergan Plc
Paratek Pharmaceuticals, Inc.
Debiopharm International SA
BioDiem Ltd
Merck & Co., Inc.
Biolytics Pharma
Redx Pharma Plc
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd.
Recce Pty Ltd
Sarepta Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Among other players domestic and global, Neisseria Gonorrhoeae Infections Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neisseria Gonorrhoeae Infections Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neisseria Gonorrhoeae Infections Treatment, with price, sales, revenue and global market share of Neisseria Gonorrhoeae Infections Treatment in 2018 and 2019.
Chapter 3, the Neisseria Gonorrhoeae Infections Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neisseria Gonorrhoeae Infections Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neisseria Gonorrhoeae Infections Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neisseria Gonorrhoeae Infections Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Neisseria Gonorrhoeae Infections Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neisseria Gonorrhoeae Infections Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cribrostatin-6
1.2.3 Dalbavancin
1.2.4 Debio-1453
1.2.5 Gepotidacin Mesylate
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neisseria Gonorrhoeae Infections Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Overview of Global Neisseria Gonorrhoeae Infections Treatment Market
1.4.1 Global Neisseria Gonorrhoeae Infections Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan Plc
2.1.1 Allergan Plc Details
2.1.2 Allergan Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan Plc SWOT Analysis
2.1.4 Allergan Plc Product and Services
2.1.5 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Paratek Pharmaceuticals, Inc.
2.2.1 Paratek Pharmaceuticals, Inc. Details
2.2.2 Paratek Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Paratek Pharmaceuticals, Inc. SWOT Analysis
2.2.4 Paratek Pharmaceuticals, Inc. Product and Services
2.2.5 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Debiopharm International SA
2.3.1 Debiopharm International SA Details
2.3.2 Debiopharm International SA Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Debiopharm International SA SWOT Analysis
2.3.4 Debiopharm International SA Product and Services
2.3.5 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioDiem Ltd
2.4.1 BioDiem Ltd Details
2.4.2 BioDiem Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioDiem Ltd SWOT Analysis
2.4.4 BioDiem Ltd Product and Services
2.4.5 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck & Co., Inc.
2.5.1 Merck & Co., Inc. Details
2.5.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck & Co., Inc. SWOT Analysis
2.5.4 Merck & Co., Inc. Product and Services
2.5.5 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biolytics Pharma
2.6.1 Biolytics Pharma Details
2.6.2 Biolytics Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biolytics Pharma SWOT Analysis
2.6.4 Biolytics Pharma Product and Services
2.6.5 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Redx Pharma Plc
2.7.1 Redx Pharma Plc Details
2.7.2 Redx Pharma Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Redx Pharma Plc SWOT Analysis
2.7.4 Redx Pharma Plc Product and Services
2.7.5 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline Plc
2.8.1 GlaxoSmithKline Plc Details
2.8.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline Plc SWOT Analysis
2.8.4 GlaxoSmithKline Plc Product and Services
2.8.5 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche Ltd.
2.9.1 F. Hoffmann-La Roche Ltd. Details
2.9.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.9.4 F. Hoffmann-La Roche Ltd. Product and Services
2.9.5 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Recce Pty Ltd
2.10.1 Recce Pty Ltd Details
2.10.2 Recce Pty Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Recce Pty Ltd SWOT Analysis
2.10.4 Recce Pty Ltd Product and Services
2.10.5 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sarepta Therapeutics, Inc.
2.11.1 Sarepta Therapeutics, Inc. Details
2.11.2 Sarepta Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sarepta Therapeutics, Inc. SWOT Analysis
2.11.4 Sarepta Therapeutics, Inc. Product and Services
2.11.5 Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sumitomo Dainippon Pharma Co., Ltd.
2.12.1 Sumitomo Dainippon Pharma Co., Ltd. Details
2.12.2 Sumitomo Dainippon Pharma Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sumitomo Dainippon Pharma Co., Ltd. SWOT Analysis
2.12.4 Sumitomo Dainippon Pharma Co., Ltd. Product and Services
2.12.5 Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neisseria Gonorrhoeae Infections Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neisseria Gonorrhoeae Infections Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 Neisseria Gonorrhoeae Infections Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Neisseria Gonorrhoeae Infections Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
4.3 Europe Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
4.5 South America Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Neisseria Gonorrhoeae Infections Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America Neisseria Gonorrhoeae Infections Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
5.3 Canada Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Neisseria Gonorrhoeae Infections Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neisseria Gonorrhoeae Infections Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
6.3 UK Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
6.4 France Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
6.5 Russia Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
6.6 Italy Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
7.3 Japan Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
7.4 Korea Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
7.5 India Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
7.7 Australia Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Neisseria Gonorrhoeae Infections Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America Neisseria Gonorrhoeae Infections Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neisseria Gonorrhoeae Infections Treatment Sales and Market Share by Type (2015-2020)
10.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global Neisseria Gonorrhoeae Infections Treatment Price by Type (2015-2020)
11 Global Neisseria Gonorrhoeae Infections Treatment Market Segment by Application
11.1 Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application (2015-2020)
11.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Application (2015-2020)
11.3 Global Neisseria Gonorrhoeae Infections Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 Neisseria Gonorrhoeae Infections Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025)
12.2.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025)
12.2.4 South America Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025)
12.3 Neisseria Gonorrhoeae Infections Treatment Market Forecast by Type (2021-2025)
12.3.1 Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global Neisseria Gonorrhoeae Infections Treatment Market Share Forecast by Type (2021-2025)
12.4 Neisseria Gonorrhoeae Infections Treatment Market Forecast by Application (2021-2025)
12.4.1 Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global Neisseria Gonorrhoeae Infections Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neisseria Gonorrhoeae Infections Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neisseria Gonorrhoeae Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neisseria Gonorrhoeae Infections Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Major Business
Table 9. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 10. Allergan Plc SWOT Analysis
Table 11. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 12. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Paratek Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Major Business
Table 15. Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 16. Paratek Pharmaceuticals, Inc. SWOT Analysis
Table 17. Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 18. Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Debiopharm International SA Basic Information, Manufacturing Base and Competitors
Table 20. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Major Business
Table 21. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 22. Debiopharm International SA SWOT Analysis
Table 23. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 24. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. BioDiem Ltd Basic Information, Manufacturing Base and Competitors
Table 26. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Major Business
Table 27. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 28. BioDiem Ltd SWOT Analysis
Table 29. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 30. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Major Business
Table 33. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 34. Merck & Co., Inc. SWOT Analysis
Table 35. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 36. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biolytics Pharma Basic Information, Manufacturing Base and Competitors
Table 38. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Major Business
Table 39. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 40. Biolytics Pharma SWOT Analysis
Table 41. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 42. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Redx Pharma Plc Basic Information, Manufacturing Base and Competitors
Table 44. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Major Business
Table 45. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 46. Redx Pharma Plc SWOT Analysis
Table 47. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 48. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Major Business
Table 51. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 52. GlaxoSmithKline Plc SWOT Analysis
Table 53. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 54. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 56. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Major Business
Table 57. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 58. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 59. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 60. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Recce Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Major Business
Table 63. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 64. Recce Pty Ltd SWOT Analysis
Table 65. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 66. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sarepta Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Major Business
Table 69. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 70. Sarepta Therapeutics, Inc. SWOT Analysis
Table 71. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 72. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sumitomo Dainippon Pharma Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Major Business
Table 75. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Total Revenue (USD Million) (2018-2019)
Table 76. Sumitomo Dainippon Pharma Co., Ltd. SWOT Analysis
Table 77. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Product and Services
Table 78. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Neisseria Gonorrhoeae Infections Treatment Sales by Manufacturer (2018-2019) (K Pcs)
Table 80. Global Neisseria Gonorrhoeae Infections Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Neisseria Gonorrhoeae Infections Treatment Sales by Regions (2015-2020) (K Pcs)
Table 82. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Regions (2015-2020)
Table 83. Global Neisseria Gonorrhoeae Infections Treatment Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Neisseria Gonorrhoeae Infections Treatment Sales by Countries (2015-2020) (K Pcs)
Table 85. North America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Countries (2015-2020)
Table 86. North America Neisseria Gonorrhoeae Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 88. Europe Neisseria Gonorrhoeae Infections Treatment Sales by Countries (2015-2020) (K Pcs)
Table 89. Europe Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Countries (2015-2020)
Table 90. Europe Neisseria Gonorrhoeae Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Sales by Regions (2015-2020) (K Pcs)
Table 92. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Neisseria Gonorrhoeae Infections Treatment Sales by Countries (2015-2020) (K Pcs)
Table 95. South America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Countries (2015-2020)
Table 96. South America Neisseria Gonorrhoeae Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Sales by Countries (2015-2020) (K Pcs)
Table 99. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries (2015-2020)
Table 102. Global Neisseria Gonorrhoeae Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 103. Global Neisseria Gonorrhoeae Infections Treatment Sales Share by Type (2015-2020)
Table 104. Global Neisseria Gonorrhoeae Infections Treatment Revenue by Type (2015-2020) (USD Million)
Table 105. Global Neisseria Gonorrhoeae Infections Treatment Revenue Share by Type (2015-2020)
Table 106. Global Neisseria Gonorrhoeae Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 107. Global Neisseria Gonorrhoeae Infections Treatment Sales Share by Application (2015-2020)
Table 108. Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Regions (2021-2025) (K Pcs)
Table 109. Global Neisseria Gonorrhoeae Infections Treatment Market Share Forecast by Regions (2021-2025)
Table 110. Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Type (2021-2025) (K Pcs)
Table 111. Global Neisseria Gonorrhoeae Infections Treatment Market Share Forecast by Type (2021-2025)
Table 112. Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Application (2021-2025)
Table 113. Global Neisseria Gonorrhoeae Infections Treatment Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neisseria Gonorrhoeae Infections Treatment Picture
Figure 2. Global Sales Market Share of Neisseria Gonorrhoeae Infections Treatment by Type in 2019
Figure 3. Cribrostatin-6 Picture
Figure 4. Dalbavancin Picture
Figure 5. Debio-1453 Picture
Figure 6. Gepotidacin Mesylate Picture
Figure 7. Others Picture
Figure 8. Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application in 2018
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global Neisseria Gonorrhoeae Infections Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Neisseria Gonorrhoeae Infections Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Manufacturer in 2019
Figure 33. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Neisseria Gonorrhoeae Infections Treatment Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Neisseria Gonorrhoeae Infections Treatment Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Neisseria Gonorrhoeae Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Regions (2015-2020)
Figure 40. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Regions in 2018
Figure 41. North America Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
Figure 42. Europe Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
Figure 44. South America Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020)
Figure 46. North America Neisseria Gonorrhoeae Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Countries (2015-2020)
Figure 48. North America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Countries in 2018
Figure 49. North America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries in 2018
Figure 51. United States Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Neisseria Gonorrhoeae Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries in 2019
Figure 57. Germany Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Regions 2019
Figure 65. China Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Neisseria Gonorrhoeae Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Countries in 2019
Figure 72. South America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries in 2019
Figure 73. Brazil Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Neisseria Gonorrhoeae Infections Treatment Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Neisseria Gonorrhoeae Infections Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Neisseria Gonorrhoeae Infections Treatment Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
髄膜炎菌感染症薬の世界市場 2020年 Market Overview The global Neisseria meningitidis Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neisse…- 人工関節感染症（PJI）治療の世界市場 2020年 Market Overview The global Prosthetic Joint Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prosthe…
- エプスタインバーウイルス（HHV-4）感染症治療の世界市場 2020年 Market Overview The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…
- アシネトバクター感染症治療の世界市場 2020年 Market Overview The Acinetobacter Infections Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- 類鼻疽菌感染症治療薬の世界市場 2020年 Market Overview The global Burkholderia Pseudomallei Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bur…